Has anyone looked into Car T Cell Therapy Immunotherapy for Advanced/Stage 4 cancer?
Anything that lessens the time in the production of Car T therapy that can assist patients hopefully achieve remission ... particularly as time is of the essence as they deteriorate quickly upon harvesting ....
CAR T cell therapy is a type of immunotherapy used to fight cancer with a patient’s own altered immune cells. T cells are taken from a patient’s blood and changed in the lab by adding a gene for a receptor (called a chimeric antigen receptor or CAR). The CAR T cells are then infused back into a patient to find, bind to, and destroy cancer cells.
Read more here:
Promising laboratory and early clinical results led to a phase I clinical trial involving patients with mesothelioma and pleural metastases from lung or breast cancer.
https://www.medpagetoday.com/meetingcoverage/asco/80318?xid=nl_mpt_DHE_2019-06-08&eun=g1307935d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202019-06-08&utm_term=NL_Daily_DHE_Active&fbclid=IwAR307MNn5WT72SGVu-TNlyXVJ_RujQxE5T9XhWg4Sapi9LN1_pfhgaL8hvU
US Company is Reducing the time to 24hr 'turnaround' ....
https://www.pennmedicine.org/news/news-releases/2022/march/penn-researchers-shorten-manufacturing-time-for-car-t-cell-therapy?fbclid=IwAR3DAdNzbXHyvdpnRfRf6QEXdIqhjt2_X-f34oGgehdlNJRK3aGknI2VI94
Australian Trials:
https://www.petermac.org/services/treatment/haematological-treatments/cellular-therapies-program/car-t/car-t-cell-clinical
CAR T cell therapy is a type of immunotherapy used to fight cancer with a patient’s own altered immune cells. T cells are taken from a patient’s blood and changed in the lab by adding a gene for a receptor (called a chimeric antigen receptor or CAR). The CAR T cells are then infused back into a patient to find, bind to, and destroy cancer cells.
Read more here:
Promising laboratory and early clinical results led to a phase I clinical trial involving patients with mesothelioma and pleural metastases from lung or breast cancer.
https://www.medpagetoday.com/meetingcoverage/asco/80318?xid=nl_mpt_DHE_2019-06-08&eun=g1307935d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202019-06-08&utm_term=NL_Daily_DHE_Active&fbclid=IwAR307MNn5WT72SGVu-TNlyXVJ_RujQxE5T9XhWg4Sapi9LN1_pfhgaL8hvU
US Company is Reducing the time to 24hr 'turnaround' ....
https://www.pennmedicine.org/news/news-releases/2022/march/penn-researchers-shorten-manufacturing-time-for-car-t-cell-therapy?fbclid=IwAR3DAdNzbXHyvdpnRfRf6QEXdIqhjt2_X-f34oGgehdlNJRK3aGknI2VI94
Australian Trials:
https://www.petermac.org/services/treatment/haematological-treatments/cellular-therapies-program/car-t/car-t-cell-clinical